The study identified rare loss-of-function and missense variants in CLCN6, a chloride channel gene, which were associated with lower diastolic BP (−3.3 mmHg) and a 28% reduction in hypertension risk (OR = 0.72). Here, CLCN6 is linked to Hypertension.